Moreover, related to MAPK inhibition, a recent study revealed that combination MEK1/2 and CDK4/6 inhibitors triggers senescence-associated secretory phenotype (SASP)–mediated increase in CD31+ cells and endothelial activation, promoting CD8+ T cell tumor infiltration in PCa [89]. The gene discussed is CD8A; the disease is posterior cortical atrophy.